Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study.
Doppenberg D, Stoop TF, van Dieren S, Katz MHG, Janssen QP, Nasar N, Prakash LR, Theijse RT, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Besselink MG; Trans-Atlantic Pancreatic Surgery (TAPS) Consortium. Doppenberg D, et al. Among authors: zureikat ah. Ann Surg Oncol. 2024 Mar;31(3):1919-1932. doi: 10.1245/s10434-023-14680-0. Epub 2024 Jan 3. Ann Surg Oncol. 2024. PMID: 38170408
Recurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence and Current Treatment.
Pulvirenti A, Javed AA, Michelakos T, Sekigami Y, Zheng J, Kalvin HL, McIntyre CA, Nebbia M, Chou JF, Gonen M, Raj N, Reidy-Lagunes DL, Zureikat AH, Ferrone CR, He J, Wei AC; PAncreatic Neuroendocrine Disease Alliance (PANDA). Pulvirenti A, et al. Among authors: zureikat ah. Ann Surg. 2023 Nov 1;278(5):e1063-e1067. doi: 10.1097/SLA.0000000000005809. Epub 2023 Jan 24. Ann Surg. 2023. PMID: 37796750
No survival benefit with suboptimal CA19-9 response: defining effective neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer.
Liu H, D'Alesio M, AlMasri S, Hammad A, Desilva A, Lebowitz S, Rieser C, Ashwat E, Hampton E, Khachfe H, Laffey M, Singhi A, Bahary N, Lee K, Zureikat A, Paniccia A. Liu H, et al. HPB (Oxford). 2023 May;25(5):521-532. doi: 10.1016/j.hpb.2023.01.016. Epub 2023 Feb 3. HPB (Oxford). 2023. PMID: 36804826 Free article.
Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula development.
Casciani F, Trudeau MT, Asbun HJ, Ball CG, Bassi C, Behrman SW, Berger AC, Bloomston MP, Callery MP, Christein JD, Falconi M, Fernandez-Del Castillo C, Dillhoff ME, Dickson EJ, Dixon E, Fisher WE, House MG, Hughes SJ, Kent TS, Malleo G, Partelli S, Salem RR, Stauffer JA, Wolfgang CL, Zureikat AH, Vollmer CM Jr; Pancreas Fistula Study Group. Casciani F, et al. Among authors: zureikat ah. Surgery. 2021 Apr;169(4):708-720. doi: 10.1016/j.surg.2020.11.022. Epub 2020 Dec 30. Surgery. 2021. PMID: 33386129
Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study.
Theijse RT, Stoop TF, Janssen QP, Prakash LR, Katz MHG, Doppenberg D, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Besselink MG. Theijse RT, et al. Among authors: zureikat ah. Br J Surg. 2024 Mar 2;111(3):znae033. doi: 10.1093/bjs/znae033. Br J Surg. 2024. PMID: 38456678 Free PMC article.
Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study.
Dekker EN, van Dam JL, Janssen QP, Besselink MG, DeSilva A, Doppenberg D, van Eijck CHJ, Nasar N, O'Reilly EM, Paniccia A, Prakash LR, Tzeng CD, Verkolf EMM, Wei AC, Zureikat AH, Katz MHG, Groot Koerkamp B; Trans-Atlantic Pancreatic Surgery (TAPS) Consortium. Dekker EN, et al. Among authors: zureikat ah. J Clin Oncol. 2024 Apr 20;42(12):1357-1367. doi: 10.1200/JCO.23.01311. Epub 2024 Feb 5. J Clin Oncol. 2024. PMID: 38315954
Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases.
Wach MM, Nunns G, Hamed A, Derby J, Jelinek M, Tatsuoka C, Holtzman MP, Zureikat AH, Bartlett DL, Ahrendt SA, Pingpank JF, Choudry MHA, Ongchin M. Wach MM, et al. Among authors: zureikat ah. Ann Surg Oncol. 2024 Apr;31(4):2391-2400. doi: 10.1245/s10434-024-14901-0. Epub 2024 Jan 25. Ann Surg Oncol. 2024. PMID: 38270826
239 results